Please assess the completion status of the following clinical trial:

Trial Title: Interest of Pregabalin (Lyrica) on the Treatment of Reflex Earache in Head and Neck Cancer.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* referred otalgia~* ENT cancer~* ASA score 1,2 or 3~* understanding protocol~* information and free and informed consent~Exclusion Criteria:~* ASA score 4 et 5~* allergy or intolerance of pregabalin~* creatinin clearance inferior of 50ml/min (Cockcroft formula)~* liver failure~* cardiac failure~* history epilepsy~* ant hyperalgesic treatment~* minor or disabled adult~* intellectual disabilities that prevent the understanding of the protocol~* uncooperative patient~* pregnant women~* patient participating in another research protocol~* lactose intolerant patient

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- pregabalin group (Type: EXPERIMENTAL): None
- Placebo group (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).